Darunavir Ethanolate is the ethanolate form of darunavir, a human immunodeficiency virus type 1 (HIV-1) protease nonpeptidic inhibitor, with activity against HIV. Upon oral administration, darunavir selectively targets and binds to the active site of HIV-1 protease, and inhibits the dimerization and catalytic activity of HIV-1 protease. It is grouped under the following drug class(es): HIV-1 protease inhibitors. Its therapeutic use is listed as anti-infectives and antivirals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Darunavir monoethanolate, Rezolsta and Prezista. Its PubChem CID is 23725083.
Darunavir ethanolate
| CAS No | 635728-49-3 |
|---|---|
| Molecular Formula | C29H43N3O8S |
| Molecular Weight | 593.7 g/mol |
| Synonyms | [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate;ethanol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Darunavir Ethanolate is the ethanolate form of darunavir, a human immunodeficiency virus type 1 (HIV-1) protease nonpeptidic inhibitor, with activity against HIV.
The listed CAS number is 635728-49-3.
The listed molecular formula is C29H43N3O8S.
The listed molecular weight is 593.7 g/mol.
[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate;ethanol.
The source lists Darunavir monoethanolate, Rezolsta and Prezista.